As Europe reaches a pivotal moment in cannabis reform, Cannabis Europa London 2025 gathers the policymakers, investors, operators, clinicians, and innovators driving the next phase of growth. From Switzerland’s pioneering adult-use pilots to France’s medical programme at a turning point, and the UK’s ongoing NHS access challenges, this year’s agenda reflects both the urgency and opportunity of a sector under transformation.
Keynotes and panels will examine the major forces shaping Europe’s cannabis future: the political pivot in Germany, the financing gaps holding back growth, the rise of new product formats and manufacturing innovations, and the growing need for credible evidence to unlock healthcare adoption and capital markets. At the heart of it all is a patient-first focus — tackling waiting lists, improving access, and defining what equitable, sustainable cannabis looks like in practice.
Cannabis Europa London 2025 is more than a stage for debate — it is where Europe’s cannabis industry decides how to scale responsibly, invest wisely, and deliver on the promise of medical and adult-use reform for millions across the continent.
Our speakers are global thought-leaders driving change in policy, research, and commerce. Hear their insights, challenge your thinking, and leave with actionable strategies.
Europe’s cannabis industry stands on the edge of its most transformative year yet. Cannabis Europa London 2025 convenes the leaders, policymakers, and pioneers shaping this next chapter — from Switzerland’s bold adult-use pilots to France’s shifting medical landscape, and Germany’s uncertain regulatory future under new political leadership.
State of Play Session: Switzerland
The Infrastructure of Access: Can Europe Scale to 5,000,000 Medical Cannabis Patients
A Sleeping Giant? A Deep Dive Into The Potential of the UK Market
Join the leading voices in cannabis policy and business. We’re proud to partner with organisations at the forefront of cannabis innovation, investment, and regulation.
Subscribe to receive the latest updates on cannabis regulation, investment, and innovation in Europe.
Cannabis Europa brings together the brightest minds in cannabis policy, business, and investment. Over two days in London, you’ll engage with policymakers, investors, scientists, and entrepreneurs to explore opportunities in one of the world’s fastest-evolving markets.
The European cannabis landscape is entering a high-growth phase, marked by the arrival of seasoned entrepreneurs and major institutional shifts. As Cannabis Europa London 2026 approaches, the first wave of speakers has been announced, highlighting a diverse intersection of pharmaceutical innovation, global policy, and venture capital. Martin Dickie MBE & Waterside Pharmaceuticals A major highlight […]
With dedicated sessions on M&A, investment, pricing strategy and market access, Cannabis Europa London 2026 is the room where Europe’s cannabis industry does business. There are cannabis conferences, and then there are the events where decisions actually get made. Cannabis Europa London has established itself as the latter—a curated gathering of the operators, investors, policymakers […]
Germany and Poland are tightening the rules on online prescribing. The ripple effects will reshape medical cannabis access across the continent. Telemedicine didn’t just support the growth of European medical cannabis—it turbocharged it. Online consultations and e-prescriptions lowered barriers for patients, expanded clinic reach beyond urban centres, and drove a surge in imports across the […]
Margins are thinning, valuations are shifting, and consolidation is coming. Here’s what operators and investors need to know heading into Cannabis Europa London. Europe’s cannabis industry has passed the point where market access alone constitutes a business model. The commercial landscape in 2026 is defined by price compression, evolving investor expectations and an M&A cycle […]
